Patent · US Active

Activation of natural cytotoxicity receptor 2 (NCR2)

US11596655B2 · kind B2 · utility

0Cited by
12References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2018
Grant dateMar 7, 2023
Priority date—
Expiry dateMay 23, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/03
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Among the various aspects of the present disclosure is the provision of methods and compositions for modulating the Natural Cyotoxicity Receptor 2 (NCR2).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.